Accelovance Purchases nTouch Research Assets

Feb 02, 2005, 00:00 ET from Accelovance

    ROCKVILLE, Md., Feb. 2 /PRNewswire/ -- Accelovance announced today that it
 has completed the asset purchase of nTouch Research, a Raleigh, N.C.-based
 site management organization (SMO).  Financial details were not disclosed.
 nTouch's clinical capabilities are a key component in Accelovance's strategy
 to provide trial management services that result in meeting trial timelines in
 a high quality and cost-effective manner.  By combining high-level targeted
 patient recruitment with quality-focused, integrated, and centralized managed
 sites, Accelovance improves productivity and quality when conducting multi-
 center Phase II through IV studies.  Building on its operations in China, the
 Company plans to add clinical sites there to further enhance global clinical
 trial enrollment and economics.
     "A strategic blend of upper management expertise, outstanding
 investigators, and the knowledge of on-site employees will allow Accelovance
 to better serve our clients.  Our vision is to revitalize the way SMOs and
 trial sponsors work together," said Accelovance President and CEO, Stephen J.
     Accelovance is a privately held company headquartered in Rockville,
 Maryland.  With over a dozen highly-rated research centers throughout the
 United States, Accelovance provides Phase II-IV clinical trial services that
 include investigator selection, patient recruitment and study management
 services for pharmaceutical, CRO, and biotechnology industries.  Accelovance
 has a commitment to sponsors, investigators and study subjects to conduct each
 study with dedication and high standards under good clinical practice (GCP)
 guidelines.  Its secondary mission is to form strong partnerships to take
 advantage of the rapidly growing medical market in China.  This will be
 accomplished by structuring relationships between partners with quality
 products and services to address unmet medical needs in China.
     For more information, visit the company's website at
     CONTACT: Stephen J. Trevisan, +1-301-222-2218, or Garrett D. Smith,
 +1-301-222-2212, both of Accelovance.

SOURCE Accelovance